Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s (OM-PEIs) for in Vivo Gene Delivery
Mitarbeiter des Rudolf-Boehm-Institutes
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Con
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Mitarbeiter des Rudolf-Boehm-Institutes
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Untersuchung der biologischen Aktivität von Nanopartikeln in Tumor- schnittkulturen
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
